ReLIA
PrivateLast Round
Growth Equity
Apr 24, 2020
Total Funding Raised
$177.6M
Company Overview
ReLIA operates in Healthcare & Life Sciences and is based in Shenzhen. Its latest recorded funding round was a Growth Equity round in April 2020.
ReLIA is a biotechnology company that develops and manufactures point-of-care testing (POCT) diagnostic equipment and reagents for cardiovascular, kidney, and inflammatory disease detection.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ReLIA Comparables
Compare ReLIA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hipro Biotechnology | 86% | |
| Chengdu Seamaty Technology Co., Ltd. | 83% | |
| Wuhan Easy Diagnosis Biomedicine Co., Ltd. | 81% |
For institutional investors. Book with your work email.
ReLIA Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Apr 24, 2020 | ||||
| Strategic | May 3, 2018 | ||||
| Strategic | Oct 18, 2017 |
For institutional investors. Book with your work email.
ReLIA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gopher Asset Management | Strategic |
| Guojin Dingxing Investment | Strategic |
| SAIF Partners | Growth Equity |
| 成都鼎兴量子投资管理有限公司 | Growth Equity |
| Yonghua Capital | Strategic |
| Efung Capital | Growth Equity |
| Bosera Asset Management | Growth Equity |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
Monthly visitors increased 156% MoM.
- May 1, 2025
Monthly visitors increased 62% MoM.
For institutional investors. Book with your work email.
ReLIA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ReLIA's valuation, stock price, and market status.
Is ReLIA a public or private company?
ReLIA is a private company.
What is the current stock price of ReLIA?
ReLIA is a private company, so its shares have no public market price. Caplight tracks ReLIA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ReLIA worth (valuation)?
Valuation information for ReLIA is not publicly available.
Can I buy ReLIA stock?
ReLIA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ReLIA's last funding round?
ReLIA's most recent funding round was Growth Equity on April 24, 2020.
Who are the main investors in ReLIA?
Key investors in ReLIA include Gopher Asset Management, Guojin Dingxing Investment, SAIF Partners, 成都鼎兴量子投资管理有限公司, Yonghua Capital.
Will ReLIA IPO soon?
No public IPO plans have been announced for ReLIA.
How can I track ReLIA secondary market activity?
Caplight tracks bids, offers, and trades in ReLIA's shares on secondary markets.